Guideline for clinical trial authorization

dc.contributor.author	Ethiopian Food and Drug Authority
dc.date.accessioned	2026-02-24T07:44:39Z
dc.date.available	2026-02-24T07:44:39Z
dc.date.issued	June 2025
dc.identifier.uri	http://repository.iphce.org/xmlui/handle/123456789/5336
dc.description.abstract	To align with QMS document control SOP formatting; to align the timeline for non-routine application review and further review for non-routine; to incorporate an evaluation timeline for safety report and CT application form and omit CT evaluation checklist.	en_US
dc.language.iso	en_US	en_US
dc.subject	Clinical trial	en_US
dc.title	Guideline for clinical trial authorization	en_US
dc.type	Guideline	en_US